Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
The American Journal of Managed Care|June 30, 2016
Overview and diagnosis of multiple sclerosisSamuel F HunterThe American Journal of Managed Care|March 4, 2015
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigmLuigi Brunetti, Samuel F HunterThe American Journal of Managed Care|March 4, 2015
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overviewMegan Maroney, Samuel F HunterDrugs|December 8, 2020
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile EffectsJerold Chun, Gavin Giovannoni, Samuel F HunterThe American Journal of Medicine|January 4, 2014
Novel therapeutics in multiple sclerosis management: clinical applicationsThomas Leist, Samuel F Hunter, Daniel Kantor, et al.CNS Drugs|December 31, 2015
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisSamuel F Hunter, James D Bowen, Anthony T RederDrugs in Context|January 7, 2021
Cost per response analysis of repository corticotropin injection <i>versus</i> other alternative treatments for acute exacerbations of multiple sclerosisGeorge J Wan, Ishveen Chopra, John Niewoehner, et al.Clinicoeconomics and Outcomes Research : CEOR|October 22, 2021
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple SclerosisSamuel F Hunter, Jas Bindra, Ishveen Chopra, et al.Nature Medicine|February 14, 1998
Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosisCynthia Rivera-Quiñones, Dorian McGavern, James D Schmelzer, et al.Advances in Therapy|June 15, 2024
Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 StudyJames D Bowen, Jessica Stulc, Samuel F Hunter, et al.Pageof 3